Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: Robert Rose who wrote (107983)	9/6/2000 3:21:48 PM
From: NOW	Respond to of 164684

Yes , but the appropriate merger would be with one of the big purveyors of internet porn

To: Robert Rose who wrote (107983)	9/6/2000 3:35:36 PM
From: H James Morris	Read Replies (1) \| Respond to of 164684

>HJ, get a whiff of this! Rob, I know this! Some time back I posted we can now smell the speculators on the Internet. Its their hot chicken garlic breath that knocks me off my net appliance. Btw Another tech wreak coming???

To: Robert Rose who wrote (107983)	9/7/2000 1:57:04 PM
From: H James Morris	Read Replies (1) \| Respond to of 164684

Rob, sniff this. >The following list contains the best performing Biotechnology stocks for the week ending September 1st. Indicated are the last trading price (Close), the point change (Chg.) and the percent change (%Chg.) for the week. The asterisk () indicates a recent IPO. Close Chg. %Chg. Telik TELK 14 6 78 3 Dimensional Phar DDDP 39 15 62 Deltagen DGEN 29 11 61 Dyax Corp DYAX 38 14 57 XOMA XOMA 12 4 49 Arena Pharmaceutic ARNA 42 12 42 Noven Pharmaceutic NOVN 42 12 40 Argonaut Technolog AGNT 17 5 38 Keryx Biopharmaceu KERX 14 4 37 Esperion Therapeut ESPR 16 4 34 Vion Pharmaceutica VION 18 4 34 AtheroGenics AGIX 11 3 33 Gene Logic GLGC 27 6 28 Progenics Pharmace PGNX 30 6 28 Lexicon Genetics LEXG 37 8 28 CuraGen CRGN 45 10 27 Pain Therapeutics PTIE 19 4 27 Guilford Pharmaceu GLFD 25 5 26 Repligen RGEN 8 2 25 Genencor Intl GCOR 30 6 25 Applied Molecular AMEV 32 6 25 The Medicines Co MDCO 25 5 24 *Genaissance Pharma GNSC 22 4 24 With the flood of 23 Biotech IPO's between mid-July and mid-August come the expiration of the quiet periods. The quiet period refers to the 25 day period following a public offering when the underwriters are not allowed to comment on the company. At the end of the quiet period, the underwriters typically offer Buy or Strong Buy recommendations on the company that can contribute to a lift in stock price. The quiet period will expire on September 4th for AtheroGenics (AGIX, $11), Esperion Therapeutics (ESPR, $16), Large Scale Biology Corp (LSBC, $32) and Regeneration Technologies (RTIX, $15). On Tuesday, the quiet period will expire for Lion Bioscience (LEON, $91) and Telik (TELK, $14). Gentleman? Start your engines! Ladies? Start your engines!